Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.38USD
15 Dec 2017
Change (% chg)

$0.08 (+3.48%)
Prev Close
$2.30
Open
$2.36
Day's High
$2.44
Day's Low
$2.27
Volume
23,883
Avg. Vol
24,511
52-wk High
$7.15
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
FY 2015 Dec '15 46.37 -13.349
Sep '15 48.62 -1.762
Jun '15 46.98 -6.152
Mar '15 33.89 -6.157
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.20 35.91
P/E High - Last 5 Yrs. -- 40.75 45.35
P/E Low - Last 5 Yrs. -- 23.60 24.23
Beta 1.67 0.92 0.91
Price to Sales (TTM) 0.20 3.92 5.95
Price to Book (MRQ) -- 4.85 5.68
Price to Tangible Book (MRQ) -- 5.73 7.29
Price to Cash Flow (TTM) -- 23.05 24.49
% Owned Institutions 20.96 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.29 5.25
Payout Ratio(TTM) -- 47.47 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -2.41 6.31 6.79
Sales (TTM) vs TTM 1 Yr. Ago -14.23 5.15 5.62
Sales - 5 Yr. Growth Rate 18.37 9.99 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 112.88 7.11 7.85
EPS (TTM) vs TTM 1 Yr. Ago 46.05 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.94
Capital Spending - 5 Yr. Growth Rate 41.15 15.15 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.91 2.49 2.55
Current Ratio (MRQ) 0.99 3.50 3.56
LT Debt to Equity (MRQ) -- 11.01 13.38
Total Debt to Equity (MRQ) -- 17.15 19.38
Interest Coverage (TTM) -3.72 49.64 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.18 55.26 54.91
Gross Margin - 5 Yr. Avg. 64.57 52.35 52.46
EBITD Margin (TTM) 6.14 -- --
EBITD - 5 Yr. Avg -0.57 18.50 15.63
Operating Margin (TTM) -69.70 14.76 6.56
Operating Margin - 5 Yr. Avg. -56.18 14.33 11.00
Pre-Tax Margin (TTM) -96.70 15.21 7.41
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.64 11.41
Net Profit Margin (TTM) -97.10 11.39 3.64
Net Profit Margin - 5 Yr. Avg. -65.04 10.98 7.70
Effective Tax Rate (TTM) -- 24.38 24.28
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 728,108 945,342,213 851,801,741
Net Income/Employee (TTM) -707,000 110,573,246 99,542,701
Receivable Turnover (TTM) 2.89 5.90 6.13
Inventory Turnover (TTM) 4.89 2.73 3.56
Asset Turnover (TTM) 0.44 0.99 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.48 11.86 11.31
Return on Assets - 5 Yr. Avg. -23.23 12.86 12.28
Return on Investment (TTM) -60.69 15.06 14.43
Return on Investment - 5 Yr. Avg. -31.36 16.81 16.07
Return on Equity (TTM) -- 16.55 16.01
Return on Equity - 5 Yr. Avg. -138.91 17.82 17.27
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.96%
# of Holders: 42
Total Shares Held: 2,416,912
3 Mo. Net Change: 189,469
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 15
# Reduced Positions: 11
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.